nad with glp 1 GLP-1-based therapies for type 2 diabetes: from single, dual and triple agonists to endogenous GLP-1 production and L-cell differentiation | Diabetology & Metabolic Syndrome Mechanisms of Action and Therapeutic

GLP-1 medications (semaglutide, tirzepatide, etc.) have helped

GLP-13/

It is currently in the Phase 3 LIVERAGE trials, which specifically target patients with F2-F3 fibrosis and includes a program for cirrhosis

GLP-1 medications can provide major health benefits, but recent studies have raised questions about a possible link with NAION, a rare optic nerve condition that can cause sudden vision loss

Blue Cross and Blue Care Network came to this decision after careful consideration of GLP-1 weight loss drugs efficacy, safety and access and skyrocketing costs.

This review explores the complex mechanisms underlying DN and highlights recent advances in diagnostic and therapeutic strategies